Details of the Drug Reposition

General Information of This Drug (ID: DMSA8RU)

Drug Name
Abatacept   DMSA8RU
Synonyms Orencia (TN)
Therapeutic Class
Antirheumatic Agents

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Systemic lupus erythematosus DISI1SZ7 4A40.0 Approved [1]
Multiple sclerosis DISB2WZI 8A40 Approved [2]
Crohn disease DIS2C5Q8 DD70 Approved [3]
Alopecia areata DIS0XXBJ ED70.2 Approved [4]
------------------------------------------------------------------------------------
2 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Rheumatoid arthritis DISTSB4J FA20 Discontinued in Phase 2 [5]
Juvenile idiopathic arthritis DISQZGBV FA24 Discontinued in Phase 2 [6]
------------------------------------------------------------------------------------

References

1 Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022 Feb 15;14:199-211.
2 Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice. Cell Commun Signal. 2023 Nov 9;21(1):321.
3 Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007 May 12;369(9573):1641-57.
4 Alopecia Areata: a Comprehensive Review of Pathogenesis and Management. Clin Rev Allergy Immunol. 2018 Feb;54(1):68-87.
5 A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
6 Studies With 1,25-Dihydroxycholecalciferol